logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
L

Ling Wang

Shenzhen Traditional Chinese Medicine Hospital
H指数:11
被引数:563

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world effectiveness of azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19 and pre-existing diabetes

阿兹夫定与奈玛特韦-利托那韦在合并糖尿病的COVID-19住院患者中的真实世界有效性比较

ISCIENCE
IF4.1
2025-02-010
OAAI
Su, Guanyue; Li, Silin; Zhang, Donghua; Zhou, Yongjian; Wang, Ling; Yuan, Yiqiang; Qian, Guowu; Li, Guotao; Han, Na; Cheng, Ming; Li, Guangming; Zhang, Shixi; Luo, Hong; Yang, Mengzhao; Zhang, Yanyang; Song, Zhan; Xing, Jiyuan; Yu, Zujiang
Real-world effectiveness and safety of azvudine in hospitalized patients with SARS-CoV-2 infection: A multicenter, retrospective cohort study

真实世界中SARS-CoV-2感染住院患者使用阿兹夫定的有效性和安全性: 一项多中心回顾性队列研究

JOURNAL OF INFECTION
IF11.9
2024-12-010
OAAI
Ren, Zhigang; Yang, Mengzhao; Su, Guanyue; Qian, Guowu; Yuan, Yiqiang; Yu, Jia; Li, Silin; Wang, Changshuang; Lu, Mingxia; Luo, Hong; Zhang, Shixi; Li, Guangming; Zhang, Donghua; Wang, Ling; Li, Guotao; Jin, Xiaoli; Wang, Juan; Wang, Mingming; Cheng, Ming; Wang, Haiyu; Chang, Junbiao; Yu, Zujiang
A retrospective cohort study of the efficacy and safety of oral azvudine versus nirmatrelvir/ritonavir in elderly hospitalized COVID-19 patients aged over 60 years

一项关于口服azvudine与nirmatrelvir/ritonavir在60岁以上老年住院COVID-19患者中疗效和安全性的回顾性队列研究

ACTA PHARMACEUTICA SINICA B
IF14.6
2024-12-010
OAAI
Yu, B; Wang, HY; Li, GM; Sun, JY; Luo, H; Yang, MZ; Zhang, YY; Liu, RH; Cheng, M; Zhang, SX; Li, GT; Wang, L; Qian, GW; Zhang, DH; Li, SL; Kan, QC; Jiang, JD; Ren, ZG
A Randomized, Open-Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID-19, a Pilot Study

阿兹夫定片治疗轻度和普通新型冠状病毒肺炎的随机，开放标签，对照临床试验，一项初步研究

ADVANCED SCIENCE
IF14.1
2020-08-13112
OAAI
Ren, Zhigang; Luo, Hong; Yu, Zujiang; Song, Jingchao; Liang, Lan; Wang, Ling; Wang, Haiyu; Cui, Guangying; Liu, Yong; Wang, Jin; Li, Qingquan; Zeng, Zhaohai; Yang, Shengkun; Pei, Guangzhong; Zhu, Yonghui; Song, Wenbin; Yu, Wenquan; Song, Chuanjun; Dong, Lihong; Hu, Chuansong; Du, Jinfa; Chang, Junbiao
A phase III clinical trial to evaluate the safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine (PPV23) in healthy children, adults, and elderly

评估23价肺炎球菌多糖疫苗 (PPV23) 在健康儿童，成人和老年人中的安全性和免疫原性的III期临床试验

HUMAN VACCINES & IMMUNOTHERAPEUTICS
IF3.5
2018-09-2120
OAAI
Huang, Lili; Wang, Ling; Li, Hong; Hu, Yuansheng; Ru, Weiping; Han, Weixiao; Shi, Gang; Ye, Qiang; Han, Zhen; Xia, Jielai; Xia, Shengli; Xu, Miao; Li, Jing

研究方向

暂未获取到该数据
H
Hong Luo
H 指数:41论文数:285被引数:6,686
Z
Zhigang Ren
H 指数:42论文数:259被引数:7,442
Z
Zujiang Yu
H 指数:34论文数:185被引数:5,403
G
Guangming Li
H 指数:58论文数:964被引数:1.4万
D
Donghua Zhang
H 指数:23论文数:316被引数:2,287
李
李国涛
H 指数:16论文数:100被引数:924
S
Silin Li
H 指数:9论文数:78被引数:501
S
Shixi Zhang
H 指数:20论文数:132被引数:1,955
M
Mengzhao Yang
H 指数:4论文数:34被引数:29
G
Guowu Qian
H 指数:3论文数:31被引数:30